Published
June 2, 2025 1:39 PM
Along with Brigitte Tenni and Belinda Townsend, Collective Member Deborah Gleeson breaks down the consequences of Trump's 'reciprocal tariffs' for access to medicines.
Deborah Gleeson
Published
Oct. 24, 2023 3:17 PM
Collective member Deborah Gleeson highlights the barriers that intellectual property rights (IPRs) present in pandemic response.
Published
Oct. 27, 2021 10:30 AM
Waiving intellectual property rights for COVID-19 health products and technologies is essential if we are to correct global health inequities and enable more equitable access, writes Collective member Deborah Gleeson.
About this blog
A blog written by members of The Political Determinants of Health Collective, where they discuss how their work contributes to furthering knowledge and research in this area.